Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
| Image |  |
|---|---|
| Description | scientific article published on 4 January 2006 |
| Author/s |
author: Tomasz Poplawski Tomasz Sliwinski Ireneusz Majsterek Tomasz Skórski Janusz Błasiak |
| Publication date | January 4, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |